13F Data
13F filer · CIK 924223

BB BIOTECH AG

SCHAFFHAUSEN, V8 · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$4.0B
+$856.5M vs prior
Positions
35
New / sold out
2 / 1
Added / reduced
14 / 6
Turnover
4.5%
buys $159.0M · sells $159.5M
Top-10 weight
64.7%

Biggest buys vs Q4 2018

ChangeSecurityShares changeChange %Est. trade value
NewCrispr Therapeutics AG+810,462–+$29.0M
AddedAudentes Therapeutics, Inc.+600,200+78.0%+$23.4M
AddedNektar Therapeutics+639,701+46.3%+$21.5M
AddedMyokardia Inc.+387,647+44.2%+$20.2M
AddedIntercept Pharmaceuticals, Inc.+121,257+21.1%+$13.6M
AddedSangamo Therapeutics, Inc+1,300,000+96.3%+$12.4M
AddedKezar Life Sciences, Inc.+402,071+49.1%+$7.1M
AddedAgios Pharmaceuticals, Inc.+100,000+3.5%+$6.7M
AddedAlnylam Pharmaceuticals, Inc.+59,700+3.8%+$5.6M
AddedEsperion Therapeutics, Inc.+130,000+3.8%+$5.2M
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q4 2018

ChangeSecurityShares changeChange %Est. trade value
ReducedIonis Pharmaceuticals Inc.-1,016,334-11.6%$-82.5M
Sold outRegeneron Pharmaceuticals Inc.-68,156-100.0%$-25.5M
ReducedIncyte Corp.-188,322-4.9%$-16.2M
ReducedVertex Pharmaceuticals Inc-70,445-5.1%$-13.0M
ReducedGilead Sciences Inc.-190,000-14.3%$-12.4M
ReducedCelgene Corp-103,875-4.5%$-9.8M
ReducedAkcea Therapeutics, Inc.-8,833-0.4%$-250.2K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $1.4BQ3 2013: $1.8BQ4 2013: $1.9BQ1 2014: $1.9BQ2 2014: $2.1BQ3 2014: $2.5BQ4 2014: $3.1BQ1 2015: $3.4BQ2 2015: $3.7BQ3 2015: $3.2BQ4 2015: $3.5BQ1 2016: $2.5BQ2 2016: $2.5BQ3 2016: $2.8BQ4 2016: $2.7BQ1 2017: $3.1BQ2 2017: $3.3BQ3 2017: $3.6BQ4 2017: $3.6BQ1 2018: $3.6BQ2 2018: $3.5BQ3 2018: $3.8BQ4 2018: $3.1BQ1 2019: $4.0B
Q2 2013Q1 2019

Holdings · Q1 2019

#SecuritySharesValueWeight
1Ionis Pharmaceuticals Inc.COM7,725,000$627.0M15.76%
2Incyte Corp.COM3,620,000$311.4M7.83%
3Neurocrine Biosciences Inc.COM3,366,786$296.6M7.46%
4Vertex Pharmaceuticals IncCOM1,300,000$239.1M6.01%
5Sage Therapeutics, Inc.COM1,375,229$218.7M5.50%
6Celgene CorpCOM2,200,000$207.5M5.22%
7Agios Pharmaceuticals, Inc.COM2,978,134$200.8M5.05%
8Alexion Pharmaceuticals, Inc.COM1,314,428$177.7M4.47%
9Alnylam Pharmaceuticals, Inc.COM1,631,089$152.4M3.83%
10Esperion Therapeutics, Inc.COM3,522,964$141.4M3.56%
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.